MIR222, microRNA 222, 407007

N. diseases: 210; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE <b>Conclusion</b>: Has-miR-222-3p and target genes<i>,</i> especially <i>CBFB</i>, <i>UBE2N</i>, may serve as prognostic predictors for HCC. 31258758 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 AlteredExpression disease BEFREE In conclusion, the elevation of miR-34a and miR-224 may be associated with both benign and malignant proliferative processes, nevertheless the increased expression of oncomiRs miR-21 and miR-222 in cirrhosis and HCC but not in FNH may be related to malignant processes of the liver. 30411298 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE In the present review, we unveiled how HBV is deciphering the cellular miRNAs like miR-26a, miR-15a, miR-16-1, miR-148a, miR-132, miR-122, miR-34a, miR-21, miR-29a, miR-222 and miR-199a/b-3p to modulate the Wnt/FZD/β-catenin signaling pathway and develop HCC. 30377095 2019
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE In this article, the effects of Chinese herbal medicines on the expression of miRNAs and their functions in the regulation of HCC have been reviewed and discussed. miRNAs such as miRNA-221 and miRNA-222 mediated by Chinese herbal medicines may be good biomarkers and therapeutic targets for HCC. 30343602 2018
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 AlteredExpression disease BEFREE Importantly, miR-93-5p, miR-221-3p, and miR-222-3p were also significantly over-expressed in human HCC. 29179453 2017
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE In conclusion, GNAI3 was down-regulated by miR-222 in HCC, and this deregulation promoted migration and invasion of HCC. 25444921 2015
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE miR‑222 regulates sorafenib resistance and enhance tumorigenicity in hepatocellular carcinoma. 25096647 2014
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 AlteredExpression disease BEFREE Increased miR-222 expression correlated significantly with advanced stage HCC and with the shorter disease-free survival of patients (P < or = 0.01). 20103675 2010
CUI: C2239176
Disease: Liver carcinoma
Liver carcinoma
0.090 Biomarker disease BEFREE Further investigations suggested the highly deregulated miR-223 and miR-222 could unequivocally distinguish HCC from adjacent nontumoral liver, irrespective of viral associations (P <or= .0002). 18555017 2008